switching from glp 1 to tirzepatide GLP-1 Agonists for MAXIMUM Weightloss Switching from a compounded to

Among patients who stopped taking tirzepatide, 31.0% doubled their weight loss after two years, 15.2% lost some additional weight, and 9.0% maintained their initial loss, with 55.2% in total maintaining or losing more weight

What led you to research GLP-1 agonists for HS

We prescribed semaglutide or liraglutide in accordance with Austrian reimbursement regulations

Heres how to set yourself up for success

Patient Concerns and Ethical Considerations with Lumigan Prescriptions When prescribing Lumigan, healthcare professionals must address patient concerns and ethical considerations for a safer and more effective bimatoprost treatment